Polynom Investment

Debos is a manufacturing firm that produces and installs digital and automatic key security for house doors and electronic devices.

PharmNovo AB is a Swedish company that specializes in developing therapeutic drugs for neuro diseases, particularly focusing on chronic pain and hyper excitability disorders. Founded in 2008 and based in Lund, the company is dedicated to creating novel Delta Opioid Receptor Agonists (DORAs) that aim to provide safe and effective alternatives to traditional opioid medications, which have been associated with addiction and toxicity. By leveraging advancements in neuroscience and translational medicine, PharmNovo seeks to address the significant unmet medical need for chronic pain treatments that affect a substantial portion of the adult population in the United States and Europe. Their lead drug candidate, PN6047, is designed to reduce chronic pain and combat hypersensitivity, ultimately improving patients' quality of life through non-addictive therapeutic options.